Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy

Circulation Journal

Volumn 72, Issue 6, 2008, Pages 893-896

  Nakazawa, Gaku ^a   Tanabe, Kengo ^a   Aoki, Jiro ^a   Onuma, Yoshinobu ^a   Higashikuni, Yasutomi ^a   Yamamoto, Hirosada ^a   Ohtsuki, Shuji ^a   Yachi, Sen ^a   Yagishita, Atsuhiko ^a   Nakajima, Hiroyoshi ^a   Hara, Kazuhiro ^a  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Angioplasty; Metallic allergy; Sirolimus eluting stents

Indexed keywords

CHROMIC ACID; MANGANESE; MOLYBDENUM; NICKEL; RAPAMYCIN; TITANIUM;

ADULT; AGED; ALLERGY; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG EFFECT; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHROMATES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; IMMUNOSUPPRESSIVE AGENTS; MALE; MANGANESE; METALS; MIDDLE AGED; MOLYBDENUM; NICKEL; PATCH TESTS; SIROLIMUS; TITANIUM; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 45849099063     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.893     Document Type: Article

References (18)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
3. Nakazawa G, Tanabe K, Aoki J, Onuma Y, Yamamoto H, Higashikuni Y, et al. Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J 2006; 70: 1367-1371.
4. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-1370.
5. Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000; 356: 1895-1897.
6. Iijima R, Ikari Y, Amiya E, Tanimoto S, Nakazawa G, Kyono H, et al. The impact of metallic allergy on stent implantation: Metal allergy and recurrence of in-stent restenosis. Int J Cardiol 2005; 104: 319-325.
7. Gotman I. Characteristics of metals used in implants. J Endourol 1997; 11: 383-389.
8. Kanerva L, Sipilainen-Malm T, Estlander T, Zitting A, Jolanki R, Tarvainen K. Nickel release from metals, and a case of allergic contact dermatitis from stainless steel. Contact Dermatitis 1994; 31: 299-303.
9. Thomas P, Summer B, Sander CA, Przybilla B, Thomas M, Naumann T. Intolerance of osteosynthesis material: Evidence of dichromate contact allergy with concomitant oligoclonal T-cell infiltrate and TH1-type cytokine expression in the peri-implantar tissue. Allergy 2000; 55: 969-972.
10. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52.
11. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230.
12. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995; 76: 412-417.
13. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715-2729.
14. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701-705.
15. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175-181.
16. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Varna S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
17. Joner M, Finn AV, Farb A, Mont EK Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
18. Aoki J, Abizaid AC, Serruys PW, Ong AT, Boersma E, Sousa JE, et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 2005; 46: 1670-1676.